-

Important Notice to Shareholders of Xtrackers II

LONDON--(BUSINESS WIRE)-- 

Xtrackers II

Investment Company with Variable Capital

Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg,

R.C.S. Luxembourg B-124.284

(the Company)

Important Notice to Shareholders of the Company

27 May 2022

The board of directors of the Company (the “Board of Directors”) hereby informs the shareholders of the Company (the “Shareholders”) about certain changes to the sub-funds of the Company (the “Sub-Funds”) permitted to undertake securities lending, as outlined below.

Capitalised terms used in this notice shall have the same meaning ascribed to them in the latest version of the prospectus of the Company (the “Prospectus”), unless the context otherwise requires.

Change of Securities Lending Agent

Deutsche Bank AG, acting through its Frankfurt am Main head office and its London and New York branches, currently acts as the securities lending agent appointed by the Company (the “Securities Lending Agent”). The Securities Lending Agent is authorised (i) to enter into Securities Lending Transactions on behalf of the Company and (ii) to invest any cash received/held on behalf of the Company as collateral pursuant to such Securities Lending Transactions (the “Securities Lending Services”).

With effect from on or around 28 June 2022 (the “Effective Date”), the Securities Lending Agent’s appointment will be terminated and the Investment Manager, DWS Investment GmbH, will take over the provision of the Securities Lending Services.

Change of the maximum proportion of assets subject to Securities Lending for Direct Replication Funds

The current Prospectus provides that a Direct Replication Fund may enter into Securities Lending Transactions for up to 50 percent of its assets (the “Maximum Securities Lending Transactions Proportion”) to generate additional income and thereby offset part or all of its costs. While all assets of a Sub-Fund which engages in Securities Lending Transactions will be eligible for such transactions (with no distinction as regards asset classes in which the Sub-Fund may invest), the expected proportion of a Sub-Fund's net assets subject to Securities Lending Transactions will typically vary between 0 percent. and 50 percent. for each relevant Sub-Fund (the “Expected Securities Lending Transactions Proportion”).

As of the Effective Date, the Maximum Securities Lending Transactions Proportion of relevant Direct Replication Funds will be increased from up to 50 percent to up to 100 percent of its assets. For the avoidance of doubt, the Expected Securities Lending Transactions Proportion will remain unchanged.

Securities Lending Fees

Currently, as provided in the relevant Product Annexes, a Sub-Fund undertaking Securities Lending Transactions is allocated 85 percent of the associated revenue generated, of which the Sub-Fund receives 70 percent, with the remaining 15 percent being received by the Sub-Portfolio Manager, DWS Investments UK Limited. The outstanding 15 percent is allocated to the Securities Lending Agent.

As of the Effective Date, the fees relating to Securities Lending Transactions will change so that the Sub-Fund is allocated 70 percent of the associated revenue generated, with the remaining 30 percent allocated to the Management Company, DWS Investment S.A.. The Management Company shall, out of the revenues allocated to it, (i) be entitled to retain 5 percent of such 30 percent amount (that is 1.5 percent of the overall associated revenue generated) as its fee for the oversight and monitoring of the securities lending activities, (ii) pay all costs and fees directly incurred in respect of securities lending activities (including custody, transaction and collateral management and administration costs), and (iii) pay such revenues as remain following payment of (i) and (ii) to the Investment Manager. The Investment Manager shall, out of the revenues it receives from the Management Company, pay all costs and expenses indirectly incurred in respect of securities lending activities (including but not limited to operational, information technology, legal, compliance and audit costs).

For the avoidance of doubt, there will be no change in the proportion of revenues generated in relation to Securities Lending Transactions attributable to the Sub-Funds, with such proportion continuing to be 70 percent of the associated revenue generated.

Changes in the Collateral Arrangements in respect of Securities Lending Transactions

In order to mitigate the counterparty risk in relation to Securities Lending Transactions, collateral may be received in accordance with the collateral arrangement set out in the Prospectus.

Currently the collateral received pursuant to Securities Lending Transactions can be held by both the Securities Lending Agent and/or The Bank of New York Mellon.

As of the Effective Date, different entities may be involved in the collateral management or administration services, depending on the lender and/or collateral management structure. More specifically, the Management Company will delegate:

  1. Collateral services for Securities Lending Transactions for certain Sub-Funds to State Street Bank International GmbH, Zweigniederlassung Frankfurt with a sub-delegation for certain Sub-Funds to Euroclear Bank SA / NV; and
  1. Management of collateral for Securities Lending Transactions for certain Sub-Funds to The Bank of New York Mellon, Bruxelles branch (Belgium) with sub-delegation to its London, New York, Orlando and Singapore branches and BNY Mellon International Operations India Private Limited, from time to time.

As of the Effective Date, the collateral eligibility requirements will also change. The section “Collateral Arrangements in respect of Securities Lending Transaction(s)” of the Prospectus will be amended to reflect the new collateral requirements.

General Information

Shareholders who subscribe for Shares in the Sub-Funds on the primary market and who do not agree with the changes, are entitled to redeem their Shares in the Sub-Funds in accordance with the Prospectus. Such redemptions shall be free of any Redemption Charge from the date of this notice until 5:00 p.m. (Luxembourg time) on 27 June 2022. Please note that the Company does not charge any redemption fee for the sale of Shares in the secondary market. Orders to sell Shares through a stock exchange can be placed via an authorised intermediary or stockbroker. Shareholders should note that orders in the secondary market may incur costs over which the Company has no control and to which the above exemption on Redemption Charges does not apply.

Copies of the revised Prospectus and the key information documents of the Sub-Funds reflecting the changes will be made available on the website of the Company (www.Xtrackers.com) on or around the Effective Date, and copies thereof may be obtained on request free of charge at the registered office of the Company or at the offices of foreign representatives, once available.

Shareholders who have any queries or to whom any of the above is not clear should seek advice from their stockbroker, bank manager, legal advisor, accountant or other independent financial advisor. Shareholders should also consult their own professional advisors as to the specific tax implications under the laws of the countries of their nationality, residence, domicile or incorporation.

Further information in relation to the changes may be obtained from the legal entities mentioned under Contact information below, the offices of foreign representatives or by sending an email to Xtrackers@dws.com.

Neither the contents of the Company's website nor the contents of any other website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

Xtrackers II

The Board of Directors

Contact Information

Xtrackers II

49, avenue J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg

DWS Investment S.A.

2, boulevard Konrad-Adenauer, L-1115 Luxembourg, Grand Duchy of Luxembourg

Contacts

Xtrackers II

Xtrackers II


Release Versions

Contacts

Xtrackers II

More News From Xtrackers II

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 29 September 2022 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”,...

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 28 September 2022 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”,...

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 27 September 2022 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”,...
Back to Newsroom